Retains spherical shape with consistent cross sectional diameter after reconstitution with aqueous-based solutions, such as contrast media and 0.9% saline solution, for predictable flow-directed level of occlusion in the vasculature.
Affords atraumatic conformability to the architecture of the vessel lumen, providing more contact surface area with the embolic material and the vessel intima, leading to a more complete occlusion of the vessel.
QuadraSphere Microspheres are a recognized and accepted platform for targeted liver embolization. QuadraSphere Microspheres are indicated for:
- Arteriovenous Malformations (AVM)
- Hypervascular Tumors (HVT)
Angiography pre- and post-embolization of hypervascularized tumor illustrate the ability of QuadraSphere Microspheres to perform a targeted embolization.*
QuadraSphere Microspheres are supplied as dry particles.
When in contact with non-ionic contrast media or normal saline (NaCI 0.9%) before delivery, QuadraSphere Microspheres expand to approximately 4x their dry state diameter.
|Catalog Number||Expanded Family Name||Size Range||Expanding Range||Delivery System||Delivery System Size||Color||Carrier Solution||Volume||HCPCS Code||GS1||GTIN Unit||GTIN Carton||GTIN Shipper|
|V225QS||QuadraSphere® Microspheres||30-60 µm||120-240 µm||Vial||10 mL||Orange||Dry||25 mg||No Applicable Code||27516||00884450275160||10884450275167||20884450275164|
|V325QS||QuadraSphere® Microspheres||50-100 µm||200-400 µm||Vial||10 mL||Light Green||Dry||25 mg||No Applicable Code||27517||00884450275177||10884450275174||20884450275171|
|V725QS||QuadraSphere® Microspheres||150-200 µm||600-800 µm||Vial||10 mL||Purple||Dry||25 mg||No Applicable Code||10609||00884450106099||10884450106096||20884450106093|